Department of Radiation Oncology, Stanford University, Stanford, California, USA.
Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
J Appl Clin Med Phys. 2023 Feb;24(2):e13859. doi: 10.1002/acm2.13859. Epub 2023 Jan 18.
Brachytherapy (BT) was the first radiotherapeutic technique used to treat human disease and remains an essential modality in radiation oncology. A decline in the utilization of BT as a treatment modality has been observed and reported, which may impact training opportunities for medical physics residents. A survey of therapeutic medical physics residency program directors was performed as part of an assessment of the current state of BT training during residency.
In March 2021, a survey consisting of 23 questions was designed by a working unit of the Brachytherapy Subcommittee of the American Association of Physicists in Medicine (AAPM) and approved for distribution by the Executive Committee of the AAPM. The survey was distributed to the directors of the Commission on Accreditation of Medical Physics Education Programs (CAMPEP)-accredited therapeutic medical physics residency programs by the AAPM. The participant response was recorded anonymously in an online platform and then analyzed using MATLAB and Microsoft Excel software.
The survey was distributed to the program directors of 110 residency programs. Over the course of 6 weeks, 72 directors accessed the survey online, and 55 fully completed the survey. Individual responses from the directors (including partial submissions) were evaluated and analyzed. Nearly all participating programs (98%) utilize high dose rate BT treatments with 74% using low dose rate BT techniques. All programs treated gynecological sites using BT, and the next most common treatment sites were prostate (80%) and breast (53%). Overall, the residency program directors had a positive outlook toward BT as a radiotherapeutic treatment modality. Caseload and time limitations were identified as primary barriers to BT training by some programs.
Based on the responses of the program directors, it was identified that the residency programs might benefit from additional resources such as virtual BT training, interinstitutional collaborations as well as resident fellowships. Programs might also benefit from additional guidance related to BT-specific training requirements to help program directors attest Authorized Medical Physicist eligibility for graduating residents.
近距离放射治疗(BT)是第一种用于治疗人类疾病的放射治疗技术,至今仍是放射肿瘤学的重要手段。BT 作为一种治疗方式的应用有所减少,这可能会影响医学物理住院医师的培训机会。作为对住院期间 BT 培训现状评估的一部分,对治疗性医学物理住院医师培训计划主任进行了调查。
2021 年 3 月,由美国医学物理学家协会(AAPM)近距离放射治疗小组委员会的一个工作组设计了一份包含 23 个问题的调查问卷,并经 AAPM 执行委员会批准分发。AAPM 将该调查问卷分发给经医学物理教育计划认证委员会(CAMPEP)认证的治疗性医学物理住院医师培训计划主任。参与者以匿名方式在在线平台上记录响应,然后使用 MATLAB 和 Microsoft Excel 软件进行分析。
该调查分发给 110 个住院医师培训计划的主任。在 6 周的时间里,有 72 名主任在线访问了该调查,其中 55 名主任完整地完成了调查。对主任的个别回复(包括部分提交内容)进行了评估和分析。几乎所有参与计划(98%)都使用高剂量率 BT 治疗,其中 74%使用低剂量率 BT 技术。所有计划都使用 BT 治疗妇科部位,其次最常见的治疗部位是前列腺(80%)和乳房(53%)。总体而言,住院医师培训计划主任对 BT 作为放射治疗方式持积极态度。一些计划认为 BT 培训的主要障碍是病例量和时间限制。
根据主任的回复,住院医师培训计划可能会受益于额外的资源,如虚拟 BT 培训、机构间合作以及住院医师奖学金。计划还可能受益于与 BT 特定培训要求相关的额外指导,以帮助主任证明即将毕业的住院医师有资格获得授权的医学物理学家。